RxDoctor Payments Data

Sabeen Ahmed, MD

Family Medicine · Edison, NJNPI 1619362225

Payments from drug & device makers

$870in general payments, 2019–2025

Across 41 payments — averaging $21.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$295
  • Novo Nordisk$125
  • Exact Sciences$73
  • Cequr Corporation$54
  • Pfizer$50
  • Novartis$43
  • plus $229 from 9 others

What the payments were for

  • Food & beverage$870100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$870 in reported general payments places this provider in the 60th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$125,769
Medicare patients
330
Services billed
1,697

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol39$45,568
OzempicSemaglutide23$40,397
EliquisApixaban26$27,883
MounjaroTirzepatide19$23,268
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$20,196
XareltoRivaroxaban13$19,722
JardianceEmpagliflozin14$17,995
JanuviaSitagliptin Phosphate14$15,567
LinzessLinaclotide13$7,077
Atorvastatin Calcium326$3,382
Ezetimibe-SimvastatinEzetimibe/Simvastatin29$2,819
Rosuvastatin Calcium209$2,650
Albuterol Sulfate HfaAlbuterol Sulfate38$2,019
Levothyroxine Sodium190$2,006
Amlodipine Besylate247$1,503

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$295$45,56839 claims
Novo NordiskOzempic$125$40,39723 claims
PfizerEliquis$50$27,88326 claims
MerckJanuvia$33$15,56714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,084 family medicine providers in New Jersey.

Other family medicine in Edison

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →